By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Mirati Therapeutics 

9363 Towne Centre Drive
Suite 200
San Diego  California  92121  U.S.A.
Phone: 858-535-2075 Fax: n/a


SEARCH JOBS


Key Statistics


Email: n/a
Ownership: Public

Web Site: Mirati Therapeutics
Employees:
Symbol: MRTX
 









Company News
Mirati Therapeutics  (MRTX) Release: Pharma Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriter's Option To Purchase Additional Shares 1/12/2017 6:04:42 AM
Mirati Therapeutics  (MRTX) Announces Pricing Of Public Offering Of Common Stock 1/6/2017 9:41:25 AM
Mirati Therapeutics  (MRTX) Announces Proposed Public Offering Of Common Stock 1/6/2017 8:34:26 AM
Mirati Therapeutics  (MRTX) Provides Update On Glesatinib And Sitravatinib Clinical Trials And Pipeline Programs 1/6/2017 8:27:36 AM
Mirati Therapeutics  (MRTX) Reports Financial Results And Provides Business Update For The Third Quarter 2016 11/4/2016 8:47:07 AM
Mirati Therapeutics  (MRTX) Appoints Chris LeMasters To Role Of Executive Vice President And Chief Business Officer 10/4/2016 6:58:42 AM
Mirati Therapeutics  (MRTX) Announces Appointment Of Dr. Bruce L.A. Carter To Board Of Directors 9/29/2016 9:21:20 AM
Mirati Therapeutics  (MRTX) Reports Financial Results And Provides Business Update For The Second Quarter 2016 8/5/2016 7:40:31 AM
San Diego's Mirati Therapeutics  (MRTX) COO Resigns to Pursue Other Opportunities 6/23/2016 5:37:49 AM
Mirati Therapeutics  (MRTX) Provides Progress Update On Current Clinical Trials 6/6/2016 11:06:46 AM
12345678
//-->